Printer Friendly

Browse Biopharmaceuticals topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
TFF Pharmaceuticals, Augmenta publish in vivo data on AUG-3387. Oct 14, 2021 543
Kintor Pharmaceutical receives Chinese regulatory approval for ALK-1 antibody and Nivolumab combination therapy clinical trial. Oct 12, 2021 236
Kintor Pharmaceutical receives Chinese regulatory approval for ALK-1 antibody and Nivolumab combination therapy clinical trial. Oct 12, 2021 237
AstraZeneca's antibody drug cocktail for treating COVID-19 shows positive results in late-stage study. Oct 11, 2021 158
AstraZeneca's antibody drug cocktail for treating COVID-19 shows positive results in late-stage study. Oct 11, 2021 159
Brii Bio Initiates Submits Emergency Use Authorization Filing to US FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk of Clinical Progression to Severe Disease. Oct 8, 2021 737
AstraZeneca seeks authorisation from US FDA for its antibody therapy to prevent COVID-19. Oct 5, 2021 182
AstraZeneca seeks authorisation from US FDA for its antibody therapy to prevent COVID-19. Oct 5, 2021 183
Brii Biosciences' neutralizing monoclonal antibody combination therapy BRII-196/BRII-198 achieved reduction in hospitalization or death among COVID-19 patients who initiated treatment within five days. Oct 4, 2021 277
Brii Biosciences' neutralizing monoclonal antibody combination therapy BRII-196/BRII-198 achieved reduction in hospitalization or death among COVID-19 patients who initiated treatment within five days. Oct 4, 2021 276
Takeda Pharmaceutical, JCR Pharmaceuticals announce JR-141 license agreement. Sep 30, 2021 213
INOVIO receives Mexican regulatory approval for INO-4800 clinical trial. Sep 23, 2021 177
INOVIO receives Mexican regulatory approval for INO-4800 clinical trial. Sep 23, 2021 176
AbCellera, Everest Medicines Forge Multi-Target Collaboration to Advance New Antibody Therapies. Sep 22, 2021 357
Chinese study indicates Sinopharm's COVID-19 vaccine booster reverses antibody decline and enhances cell-based responses. Sep 17, 2021 160
Chinese study indicates Sinopharm's COVID-19 vaccine booster reverses antibody decline and enhances cell-based responses. Sep 17, 2021 161
Eli Lilly and Company announces further US deal for COVID-19 neutralising antibody therapies. Sep 16, 2021 152
Eli Lilly and Company announces further US deal for COVID-19 neutralising antibody therapies. Sep 16, 2021 153
CHURN. Lee, Peter Sep 1, 2021 27608
Coronavirus: Study finds vaccines produce higher antibody count than infection. Staff Reporter Aug 31, 2021 254
Innovent Biologics signs drug research and development collaboration with Bolt Biotherapeutics. Aug 27, 2021 280
Innovent Biologics signs drug research and development collaboration with Bolt Biotherapeutics. Aug 27, 2021 281
Bolt Biotherapeutics and Innovent to collaborate on new oncology ISAC programs. Aug 26, 2021 253
NGM Biopharmaceuticals discloses fourth oncology development candidate, NGM831. Aug 23, 2021 160
AstraZeneca's antibody therapy prevents Covid-19, study shows. Reuters News Service Drug overview Aug 20, 2021 518
AstraZeneca's antibody therapy prevents Covid -and could be an alternative to jabs; AstraZeneca's antibody therapy has been found to prevent Covid in a late-stage study, paving the way for it to be potentially used as an alternative to jabs for those with weakened immunity. By, Ryan Merrifield Aug 20, 2021 401
HDT Bio Inks Agreement with Korea's Quratis to Co-Develop Innovative COVID-19 Vaccine in Asia. Aug 16, 2021 380
Moderna COVID-19 vaccine maintains antibody response to variants of concern at six months. Aug 13, 2021 180
Moderna COVID-19 vaccine maintains antibody response to variants of concern at six months. Aug 13, 2021 181
Moderna's new study showing COVID vaccine maintains antibodies for six months. Aug 12, 2021 241
Moderna Hightlights New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months. Report Aug 12, 2021 455
'I had very mild side effects' Virus: Pregnant women who get mRNA vaccines may pass antibodies on to children. Marni Pyke mpyke@dailyherald.com Aug 10, 2021 426
NGM Biopharmaceuticals reports Q2 EPS (48c), consensus (37c). Financial report Aug 9, 2021 182
Don't limit innovation; it's the only route to a healthier world. O'Brien, John Aug 9, 2021 766
Adagio Therapeutics Partners with Biocon Biologics to Bring COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets. Jul 27, 2021 461
Day One Biopharmaceuticals receives FDA Rare Pediatric Designation for DAY101. Jul 27, 2021 174
AstraZeneca Regeneron to commercialize new small molecule medicines for obesity. Jul 27, 2021 156
The National Institute for Innovation in Manufacturing Biopharmaceuticals receives USD153m in new funding. Jul 15, 2021 173
The National Institute for Innovation in Manufacturing Biopharmaceuticals receives USD153m in new funding. Jul 15, 2021 174
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia. Jul 9, 2021 252
Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. Jul 6, 2021 270
Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. Jul 6, 2021 271
Study finds Delta strain in India 8 times less sensitive to COVID-19 vaccine antibodies. Jul 6, 2021 155
Antibody drug conjugate's partners. Jul 5, 2021 399
NGM, Merck amend collaboration to focus on medicines for retinal, CVM diseases. Jul 1, 2021 552
Mixing vaccines results in more antibodies - study. NINA MASSEY newsdesk@walesonline.co.uk Jun 30, 2021 267
Clover Biopharmaceuticals to supply up to 414 million doses of its COVID-19 vaccine to global COVAX scheme. Jun 30, 2021 176
Clover Biopharmaceuticals to supply up to 414 million doses of its COVID-19 vaccine to global COVAX scheme. Jun 30, 2021 177
Eiger BioPharmaceuticals reports 'positive' Phase 2 results of Avexitide. Clinical report Jun 28, 2021 178
Study: Oxford-AstraZeneca vaccine develops antibodies in 93% recipients after 2nd dose. Jun 27, 2021 288
Seven and Eight Biopharmaceuticals Inc. Announces the First Patient Treated in a First-in-Human Clinical Trial of the TLR7/8 Dual Agonist BDB018 in Advanced Solid Tumors. Jun 23, 2021 271
LegoChem Biosciences, Iksuda Therapeutics Expand License Agreement for Development of Antibody-Drug Conjugates. Jun 22, 2021 259
Bristol Myers Squibb signs global strategic collaboration for Eisai's MORAb-202 antibody drug conjugate. Jun 21, 2021 262
Bristol Myers Squibb signs global strategic collaboration for Eisai's MORAb-202 antibody drug conjugate. Jun 21, 2021 263
Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate. Jun 18, 2021 634
Eight in 10 have virus antibodies as vaccine campaign drives forward. PIPPA ARMSTRONG newsdesk@mnamedia.co.uk Jun 10, 2021 299
Eight in 10 have virus antibodies as vaccine campaign drives forward. PIPPA ARMSTRONG newsdesk@mnamedia.co.uk Jun 10, 2021 299
INOVIO expands Advaccine Biopharmaceuticals Suzhou collaboration to conduct global Phase three COVID-19 DNA Vaccine Candidate trial. Jun 9, 2021 256
INOVIO expands Advaccine Biopharmaceuticals Suzhou collaboration to conduct global Phase three COVID-19 DNA Vaccine Candidate trial. Jun 9, 2021 257
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch. Jun 7, 2021 467
UK trial for tobacco based Covid vaccine that 'boosts antibodies ten-fold'; Clinical trials are now being launched across the world, including in the UK. By, Max Channon & Mark Waghorn, SWNS Jun 6, 2021 642
TOP NEWS: Pfizer vaccine has lower antibodies targeting Indian variant. Jun 4, 2021 859
Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2. Palma, Marco Jun 1, 2021 8936
MyBio Launches Covid-19 Rapid Test That Can Verify Antibody Response to Any Vaccine. May 27, 2021 365
Paradigm Biopharmaceuticals receives US FDA feedback on IND application for PPS in knee OA. May 26, 2021 264
Paradigm Biopharmaceuticals receives US FDA feedback on IND application for PPS in knee OA. May 26, 2021 264
FDA issues EUA for Vir and GSK's COVID-19 antibody therapy. May 26, 2021 164
Navidea Biopharmaceuticals Issued US Patent for Diagnosis and Treatment of Viral Infections. Disease/Disorder overview May 20, 2021 273
Canada's Medicago COVID-19 vaccine candidate shows strong antibody response in mid-stage study. May 18, 2021 180
Canada's Medicago COVID-19 vaccine candidate shows strong antibody response in mid-stage study. May 18, 2021 179
Clover Biopharmaceuticals COVID-19 vaccine candidate shows immune response during animal testing. May 18, 2021 171
Clover Biopharmaceuticals COVID-19 vaccine candidate shows immune response during animal testing. May 18, 2021 172
UK study indicates delay of second Pfizer COVID-19 vaccine dose produces more antibodies. Report May 14, 2021 194
UK study indicates delay of second Pfizer COVID-19 vaccine dose produces more antibodies. Report May 14, 2021 195
First Patient Dosed in FIREFLY-1 Pivotal Phase 2 Clinical Trial of DAY101 in Pediatric Progressive Low-Grade Glioma. May 12, 2021 895
NGM Biopharmaceuticals reports Q1 EPS (36c), consensus (42c). Clinical report May 6, 2021 172
Eiger BioPharmaceuticals adds Lambda to multi-centre Phase 3 TOGETHER COVID-19 study in Brazil. Clinical report May 4, 2021 224
Eiger BioPharmaceuticals adds Lambda to multi-centre Phase 3 TOGETHER COVID-19 study in Brazil. Clinical report May 4, 2021 225
Paradigm Biopharmaceuticals progresses IND application with US FDA for knee OA treatment. Apr 27, 2021 319
Samsung Biologics expands drug manufacturing with TG Therapeutics. Apr 26, 2021 522
Paradigm Biopharmaceuticals doses first participant in Para_OA_008 clinical trial exploring knee OA synovial biomarkers. Apr 15, 2021 349
Lonza partners with aTyr for development of novel therapeutic antibody. Apr 15, 2021 166
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities. Apr 15, 2021 312
Pure Biologics picks Twist Bioscience to expand phage display technology ability. Apr 14, 2021 205
FairJourney Biologics Enters Antibody Discovery Collaboration with Argenx. Apr 13, 2021 193
Twist Bioscience to provide antibody discovery, for drug research to Stanford. Apr 7, 2021 283
Abcellera Cites Published Data Supporting Bamlanivimab High Potency Against SARS-CoV-2 and Support its Use as a Foundational Antibody Therapy to Treat and Prevent COVID-19. Apr 6, 2021 1108
Berkeley Lights announce Opto Assure for manufacturability of antibody therapy. Apr 5, 2021 163
Boost for cancer, haemophilia and arthritis treatments as University of Edinburgh takes lead on biotech project; A multi-million-pound collaboration led by the University of Edinburgh and a major biotech firm is set to develop more cost-effective ways to make antibody-based medicines. Scott Reid Apr 2, 2021 567
Paradigm Biopharmaceuticals in new collaboration with bene pharmaChem to co-fund new projects to unlock potential of injectable PPS. Apr 1, 2021 566
China's Clover Biopharmaceuticals starts COVID-19 clinical trials in PH -- DOST. Mar 29, 2021 184
BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. Mar 25, 2021 269
BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. Mar 25, 2021 270
Navidea Biopharmaceuticals' net loss widens to USD11.4m in 2020. Financial report Mar 25, 2021 186
New oral Covid-19 vaccine candidate 'produces antibodies after a single dose'. Mar 23, 2021 359
Paradigm Biopharmaceuticals' Phase 2A Ross River Virus clinical trial results peer-reviewed and published online in BMC Musculoskeletal Disorders journal. Mar 19, 2021 732
New Drug Uses Monoclonal Antibodies: Initial research shows frunevetmab may treat arthritis pain. Mar 17, 2021 204
ImmunoPrecise Antibodies Releases Results from a Comprehensive Screening of 27 Proprietary Anti-SARS-CoV-2 Therapeutic Antibodies. Mar 16, 2021 298
New evidence shows COVID-19 antibodies, vaccines less effective against variants. Mar 5, 2021 421
Paradigm Biopharmaceuticals boosts finances with $3.38 million R&D tax refund from Australian Government. Feb 24, 2021 329
China's Clover Biopharmaceuticals raises USD230m from investors to develop vaccines for COVID-19 virus variants. Feb 23, 2021 229
China's Clover Biopharmaceuticals raises USD230m from investors to develop vaccines for COVID-19 virus variants. Feb 23, 2021 233
Paradigm Biopharmaceuticals receives ethics approval for Phase 2 clinical trial of PPS in knee osteoarthritis pain. Feb 19, 2021 810
Eli Lilly's antibody therapy authorised for emergency use by US FDA to treat COVID-19. Feb 10, 2021 220
Eli Lilly's antibody therapy authorised for emergency use by US FDA to treat COVID-19. Feb 10, 2021 216
Czech Republic's health ministry recommends use of Eli Lilly's and Regeneron's COVID-19 antibody therapies. Feb 8, 2021 235
Czech Republic's health ministry recommends use of Eli Lilly's and Regeneron's COVID-19 antibody therapies. Feb 8, 2021 239
Paradigm Biopharmaceuticals' additional data on ZilosulA patients under the TGA SAS shows very consistent reduction in pain of nearly 50%. Feb 4, 2021 703
Evozyne signs strategic development collaboration with leading company in rare disorders. Feb 2, 2021 162
Evozyne signs strategic development collaboration with leading company in rare disorders. Feb 2, 2021 158
COVID-19 trials: Antibody drugs fail against new variants. Arab News Feb 2, 2021 372
Participants developed antibodies CanSino vaccine trial concludes. Jan 25, 2021 263
Lilly: Antibody drug can prevent COVID-19 illness in nursing homes. TOM MURPHY AP Health Writer Jan 22, 2021 519
TRIGR Therapeutics signs licensing agreement with Elpiscience Biopharmaceuticals. Jan 21, 2021 165
TRIGR Therapeutics signs licensing agreement with Elpiscience Biopharmaceuticals. Jan 21, 2021 161
DGHS mulling antibody tests to measure vaccine efficacy. Jan 20, 2021 254
Paradigm Biopharmaceuticals lays out roadmap for the future at JP Morgan Healthcare Conference. Conference news Jan 15, 2021 766
Paradigm Biopharmaceuticals to present at the annual JP Morgan healthcare conference next week. Conference news Jan 7, 2021 353
US Renal Care to Administer IV Monoclonal Antibody Therapy in Dialysis Clinics to Confirmed COVID-19 Patients. Dec 30, 2020 299
Russia to test new COVID-19 antibody drug in new year. Dec 28, 2020 362
Paradigm Biopharmaceuticals proceeding with IND submission for ZilosulA for osteoarthritis after positive FDA Type C meeting feedback. Dec 19, 2020 593
South Korea's Celltrion's COVID-19 antibody treatment drug approved for patients. Dec 15, 2020 166
South Korea's Celltrion's COVID-19 antibody treatment drug approved for patients. Dec 15, 2020 170
Paradigm Biopharmaceuticals to host first R&D presentation this month to update on Zilosul pipeline. Dec 9, 2020 402
Clover Biopharmaceuticals Touts Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates. Dec 7, 2020 511
Exelixis In-Licenses Iconic Therapeutics' Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application. Dec 3, 2020 461
US government to commence distribution of Regeneron's COVID-19 antibody therapy to states on 24 November. Nov 24, 2020 235
US government to commence distribution of Regeneron's COVID-19 antibody therapy to states on 24 November. Nov 24, 2020 231
Innovent Biologics reveals results of TYVYT phase three ORIENT-32 study at European Society of Medical Oncology Asia Virtual Congress 2020. Nov 23, 2020 348
US FDA approves Eiger BioPharmaceuticals' ZokinvyTM. Nov 23, 2020 219
Innovent Biologics reveals results of TYVYT phase three ORIENT-32 study at European Society of Medical Oncology Asia Virtual Congress 2020. Nov 23, 2020 344
US FDA approves Eiger BioPharmaceuticals' ZokinvyTM. Nov 23, 2020 215
US to begin distributing Regeneron's COVID-19 antibody therapy Tuesday. Reuters News Service Nov 23, 2020 320
NeuroScientific Biopharmaceuticals to investigate treatment for post-COVID fibrosis. Nov 21, 2020 532
Kangpu Biopharmaceuticals starts Phase Ib/IIa clinical study of KPG-818 in Systemic Lupus Erythematosus patients. Nov 18, 2020 177
Kangpu Biopharmaceuticals starts Phase Ib/IIa clinical study of KPG-818 in Systemic Lupus Erythematosus patients. Nov 18, 2020 181
Navidea Biopharmaceuticals Touts Positive Results Encompassing Additional Patients from Its Ongoing Phase 2B Study in Rheumatoid Arthritis. Clinical report Nov 16, 2020 336
Paradigm Biopharmaceuticals initiates Mucopolysaccharidosis type I open label Phase II clinical trial with first patient dosed. Nov 13, 2020 659
Navidea Biopharmaceuticals reports positive findings in RA study. Nov 13, 2020 283
Navidea Biopharmaceuticals reports positive findings in RA study. Nov 13, 2020 287
US FDA allows emergency use of first COVID-19 antibody drug from Eli Lilly. Nov 10, 2020 322
US FDA allows emergency use of first COVID-19 antibody drug from Eli Lilly. Nov 10, 2020 326
Celltrion's Phase 1 study of its COVID-19 antibody drug shows improvement in recovery time. Nov 6, 2020 252
Regeneron hopeful of early authorisation by US of its COVID-19 antibody drug. Nov 6, 2020 190
Celltrion's Phase 1 study of its COVID-19 antibody drug shows improvement in recovery time. Nov 6, 2020 256
Regeneron hopeful of early authorisation by US of its COVID-19 antibody drug. Nov 6, 2020 194
CEPI partners with Clover Biopharmaceuticals to fund S-Trimer COVID-19 vaccine candidate via Global Phase 2/3 Study. Nov 3, 2020 364
CEPI partners with Clover Biopharmaceuticals to fund S-Trimer COVID-19 vaccine candidate via Global Phase 2/3 Study. Nov 3, 2020 360
TFF Pharmaceuticals, Augmenta Bioworks Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies. Nov 2, 2020 603
Genmab, ADC Therapeutics execute amended agreement for Cami. Oct 30, 2020 259
TFF Pharmaceuticals pact with UGA announces preclinical results in flu vaccine. Financial report Oct 27, 2020 176
Trump gets Gilead drug, Regeneron antibody mix. Oct 19, 2020 852
Evotec receives grant from the Bill & Melinda Gates Foundation to evaluate antibody drugs for COVID-19. Oct 19, 2020 251
Evotec receives grant from the Bill & Melinda Gates Foundation to evaluate antibody drugs for COVID-19. Oct 19, 2020 255
Eiger BioPharmaceuticals Touts Positive Results of Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19. Oct 16, 2020 675
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 161
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 165
Sanofi, Translate Bio: COVID-19 vaccine candidate induced high antibody levels. Oct 15, 2020 322
Eiger BioPharmaceuticals' Interferon Lambda shows COVID-19 load decline in trial. Oct 15, 2020 247
Eli Lilly pauses trial of its COVID-19 antibody drug over safety concern. Oct 14, 2020 325
Eli Lilly pauses trial of its COVID-19 antibody drug over safety concern. Oct 14, 2020 329
Celltrion gets approval for Phase 3 trials of COVID-19 antibody drug from South Korea's regulatory authority. Oct 12, 2020 235
Celltrion gets approval for Phase 3 trials of COVID-19 antibody drug from South Korea's regulatory authority. Oct 12, 2020 239
Regeneron applies to US FDA for EUA for its COVID-19 antibody therapy. Oct 8, 2020 230
Regeneron applies to US FDA for EUA for its COVID-19 antibody therapy. Oct 8, 2020 234
Eli Lilly's therapy with COVID neutralizing antibodies reduced viral load. Clinical report Oct 7, 2020 274
Regeneron - the experimental antibody drug given to Pres. Trump. Oct 4, 2020 525
Paradigm Biopharmaceuticals data shows Zilosul reduces pain in patients with knee osteoarthritis. Oct 2, 2020 630
Paradigm Biopharmaceuticals extends exclusive supply agreement with bene pharmaChem. Sep 30, 2020 530
Paradigm Biopharmaceuticals has clear path towards ZilosulA OA Phase 3 clinical trial and product registration in Europe. Sep 29, 2020 574
Clover Biopharmaceuticals Touts Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate. Sep 25, 2020 683
Clover Biopharmaceuticals Forms Global Scientific Advisory Board for its COVID-19 Vaccine Programme. Sep 25, 2020 858
MediciNova's intranasal COVID-19 vaccine prototype induces antibodies in mice. Sep 23, 2020 176
Celltrion's COVID-19 antibody drug approved for Phase 2/3 trials in South Korea. Sep 17, 2020 174
Celltrion's COVID-19 antibody drug approved for Phase 2/3 trials in South Korea. Sep 17, 2020 170
Lilly, Amgen Forge Manufacturing Collaboration for COVID-19 Antibody Therapies. Sep 17, 2020 174
Lilly, Amgen Forge Manufacturing Collaboration for COVID-19 Antibody Therapies. Sep 17, 2020 174
SK Biopharmaceuticals plans phase three clinical trial for cenobamate in Asia. Sep 14, 2020 216
SK Biopharmaceuticals plans phase three clinical trial for cenobamate in Asia. Sep 14, 2020 220
Celltrion in South Korea plans commercial production of COVID-19 antibody drug. Sep 8, 2020 248
Celltrion in South Korea plans commercial production of COVID-19 antibody drug. Sep 8, 2020 252
Biopharmaceuticals battling COVID-19 pandemic to connect with investors via Proactive One2One Investor Forum on September 10. Sep 5, 2020 1783
Results of Russia's COVID-19 vaccine produced antibody response -- The Lancet. Reuters News Service Sep 4, 2020 715
Results of Russia's vaccine produced antibody response. Reuters News Service Sep 4, 2020 713
Twist Bioscience Releases Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Programme. Sep 3, 2020 545
Eiger BioPharmaceuticals announces results from Phase 2 LIFT HDV study. Aug 31, 2020 161
Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome. Petrillo, Alessandra; Biran, Noa; Sadikot, Sean Aug 31, 2020 1892
BeiGene Inks Exclusive License Agreement for Neutralizing COVID-19 Antibodies Developed by Singlomics Biopharmaceuticals. Clinical report Aug 27, 2020 547
AstraZeneca starts trial of antibody medication that prevents and treats Covid-19 infections; Drug has the potential to act as a preventative for people exposed to the virus as well as to treat patients already infected. By, Brett Gibbons Aug 25, 2020 336
Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Closes Adgero Biopharmaceuticals Acquisition. Aug 20, 2020 375
Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Closes Adgero Biopharmaceuticals Acquisition. Aug 20, 2020 403
Regeneron Pharmaceuticals and Roche collaborate to increase production of COVID-19 antibody therapy. Aug 19, 2020 201
Regeneron Pharmaceuticals and Roche collaborate to increase production of COVID-19 antibody therapy. Aug 19, 2020 205
Memo Therapeutics AG, Northway Biotechpharma Team on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19. Aug 17, 2020 510
Before a vaccine, development of antibody drugs. Associated Press Aug 13, 2020 388
SK Biopharmaceuticals fails to join MSCI Korea Index. Aug 13, 2020 493
Paradigm Biopharmaceuticals receives critical approvals and feedback from agencies to progress MPS. Aug 12, 2020 724
Seattle Genetics Achieves Milestone Payment Under Antibody-Drug Conjugate Collaboration with GlaxoSmithKline Triggered by Blenrep FDA Approval. Aug 7, 2020 402
ImmunoPrecise Antibodies Ltd's IPA's human anti-SARS-CoV-2 therapeutic antibodies shows synergistic neutralization. Aug 3, 2020 219
ImmunoPrecise Antibodies Ltd's IPA's human anti-SARS-CoV-2 therapeutic antibodies shows synergistic neutralization. Aug 3, 2020 215
Voyager provides update on AbbVie vectorized antibody collaborations. Aug 3, 2020 325
Paradigm Biopharmaceuticals higher on reporting 65% pain reduction in OA patients treated under US FDA EAP. Jul 31, 2020 675
Sorrento to Acquire SmartPharm to Develop Gene-Encoded Therapeutic Antibodies to Treat COVID-19 and Cancer. Jul 28, 2020 181
Sorrento to Acquire SmartPharm to Develop Gene-Encoded Therapeutic Antibodies to Treat COVID-19 and Cancer. Jul 28, 2020 214
NGM Biopharmaceuticals initiates Phase 2 CATALINA study of NGM621. Jul 27, 2020 210
Workers "want vaccine or antibody test" before returning to the office; Some want to see temperature checks -and women are more concerned than men. By, Alan Jones & Lorna Hughes Jul 27, 2020 311
Paradigm Biopharmaceuticals set to release results of FDA's IND expanded access program for Zilosul osteoarthritis treatment. Jul 16, 2020 689
The case for Covid-19 antibody therapies. Jul 15, 2020 884
Antibody therapies offer hope. Michel Goldman & Michel D. Kazatchkine Jul 13, 2020 810
Zymeworks announces new multispecific antibody collaboration with Merck. Jul 8, 2020 154
OP-ED: The truth about vaccines and rapid antibody test kits. Jul 4, 2020 2135
GL VENTURES INVESTS IN CLOVER BIOPHARMACEUTICALS. Jul 1, 2020 400
Wuhan Institute of Biological Products' first inactivated COVID-19 vaccine produces antibodies. Clinical report Jun 24, 2020 194
Wuhan Institute of Biological Products' first inactivated COVID-19 vaccine produces antibodies. Clinical report Jun 24, 2020 190
SK Biopharmaceuticals to make big splash in stock market. Jun 23, 2020 469
Seattle Genetics Initiates Phase 1 Clinical Trials for Two Novel Antibody-Based Drug Candidates. Jun 22, 2020 523
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate. Jun 19, 2020 653
Vyripharm Biopharmaceuticals and Regis Technologies Ink Master Drug Program Agreement for Expediting cGMP Manufacture of Antiviral Agents for Diagnostic Evaluation of COVID-19. Jun 17, 2020 330
Sanofi says enzyme replacement therapy shows 'meaningful improvement' in LOPD. Jun 16, 2020 488
Sinovac Biotech in China reports its experimental COVID-19 vaccine induces antibodies. Jun 15, 2020 241
Sinovac Biotech in China reports its experimental COVID-19 vaccine induces antibodies. Jun 15, 2020 245
Integral Molecular to implement Membrane Proteome Array technology for antibody specificity profiling for development of SARS-CoV-2 therapeutic antibodies. Jun 15, 2020 170
Integral Molecular to implement Membrane Proteome Array technology for antibody specificity profiling for development of SARS-CoV-2 therapeutic antibodies. Jun 15, 2020 174
DelMar to Acquire Adgero Biopharmaceuticals in Stock Deal. Jun 11, 2020 340
DelMar to Acquire Adgero Biopharmaceuticals in Stock Deal. Jun 11, 2020 313
DelMar Pharmaceuticals to acquire Adgero Biopharmaceuticals in-all equity deal. Jun 10, 2020 242
Alphamab Oncology partners with Sanofi for studying Taxotere and KN026 combination in treating HER2+ breast cancer. Jun 9, 2020 238
Alphamab Oncology partners with Sanofi for studying Taxotere and KN026 combination in treating HER2+ breast cancer. Jun 9, 2020 234
Alphamab Oncology and Sanofi collaborate on KN026 in HER2+ breast cancer. Jun 9, 2020 247
AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center forms partnership to develop monoclonal antibody therapy to prevent and treat COVID-19. Jun 8, 2020 185
AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center forms partnership to develop monoclonal antibody therapy to prevent and treat COVID-19. Jun 8, 2020 189
Scientists near antibody treatment breakthrough; MEDICINE. BENJAMIN COOPER Jun 8, 2020 268
Innovent Biologics to partner with Roche on product development. Jun 8, 2020 163
Antibody drugs could help curb pandemic, Barron's says. Jun 6, 2020 162
AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Team to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19. Jun 5, 2020 227
Paradigm Biopharmaceuticals strengthens team with additional clinical and commercial expertise. Jun 4, 2020 551
NYU Langone Enrolls Patients in Clinical Trial for COVID-19 Antibody Therapy. Jun 1, 2020 300
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. Uddin, Md. Sahab; Kabir, Md. Tanvir; Jeande, Philippe; Mathew, Bijo; Ashraf, Ghulam Md; Perveen, Asm May 31, 2020 14406
Innovent Biologics doses first China patient in phase one clinical trial. May 26, 2020 289
Innovent Biologics doses first China patient in phase one clinical trial. May 26, 2020 285
US FDA accepts Eiger BioPharmaceuticals' New Drug Application for accelerated Zokinvy review. May 20, 2020 299
US FDA accepts Eiger BioPharmaceuticals' New Drug Application for accelerated Zokinvy review. May 20, 2020 303
SK Biopharmaceuticals to be listed in June. May 20, 2020 452
Paradigm Biopharmaceuticals share register continues to globalise with upcoming catalysts. May 13, 2020 586
Navidea Biopharmaceuticals Regains Commercialisation and Distributions Rights in Europe for Lymphoseek. May 11, 2020 400
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals. May 6, 2020 171
Applied DNA says DNA vaccine candidates produced antibodies in animals. May 4, 2020 242
Paradigm Biopharmaceuticals completes Zilosul dosing under FDA's Expanded Access Program. May 1, 2020 437
Eiger BioPharmaceuticals doses first patient in phase two study of peginterferon lambda in outpatients with mild COVID-19. May 1, 2020 265
Eiger BioPharmaceuticals doses first patient in phase two study of peginterferon lambda in outpatients with mild COVID-19. May 1, 2020 269
SCL Health partners with Mayo Clinic for CP transfusions for COVID-19 antibody therapy. Apr 24, 2020 180
SCL Health partners with Mayo Clinic for CP transfusions for COVID-19 antibody therapy. Apr 24, 2020 184
Paradigm Biopharmaceuticals has significant clarity on development pathway for Zilusol: Bell Potter. Apr 21, 2020 1133
Synthon Biopharmaceuticals Relaunches as Byondis. Apr 16, 2020 520
Arecor pushes to meet unmet needs in diabetes care. Apr 15, 2020 609
Sutro to present data for STRO-002 antibody-drug conjugate at the AACR. Apr 13, 2020 164
Paradigm Biopharmaceuticals completes $35 million capital raising. Apr 9, 2020 383
Vidscrip collaborates with AstraZeneca to launch COVID-19-specific messaging to US physicians. Apr 8, 2020 209
Vidscrip collaborates with AstraZeneca to launch COVID-19-specific messaging to US physicians. Apr 8, 2020 205
Paradigm Biopharmaceuticals confirms knee osteoarthritis pain reduction ahead of phase 3 clinical trial of Zilosul. Apr 7, 2020 637
Are thermogenic proteins and adipokine chemerin afected by monoclonal antibody therapy in asthma? Bulut, Tangul; Yalcin, Arzu Didem; Celik, Betul; Genc, Gizem Esra; Gocmen, Ayse Yesim; Gumuslu, Saad Apr 3, 2020 3572
Paradigm Biopharmaceuticals in halt pending response to Food & Drug Administration update. Apr 3, 2020 430
Neurimmune partners with Ethris to develop inhaled mRNA-based antibody therapy for treating COVID-19 patients. Apr 1, 2020 215
Neurimmune partners with Ethris to develop inhaled mRNA-based antibody therapy for treating COVID-19 patients. Apr 1, 2020 219
Angiokeratomas and treatment with enzyme replacement therapy in a patient with Fabry disease. Sabovic, Eva Klara Merzel; Tansek, Mojca Zerjav; Groselj, Urh; Dragos, Vlasta Apr 1, 2020 2529
Paradigm Biopharmaceuticals commences ZilosulA treatment for expanded access program. Mar 25, 2020 647
Dynavax, Clover Biopharmaceuticals announce research collaboration. Mar 24, 2020 204
Samsung Biologics forges Alzheimer's drug development partnership with Taiwan firm. Mar 17, 2020 470
ImmunoPrecise Antibodies unveils new therapy approach in bid to tackle coronavirus. Mar 13, 2020 416
AbCellera partners with Lilly to co-develop antibody therapies for treatment of COVID-19. Mar 13, 2020 232
AbCellera partners with Lilly to co-develop antibody therapies for treatment of COVID-19. Mar 13, 2020 228
Eli Lilly, AbCellera partner to co-develop COVID-19 antibody therapies. Mar 12, 2020 191
ImmunoPrecise forges AI collaboration with EVQLV to discover vaccine and antibodies for coronavirus. Mar 3, 2020 755
TOP NEWS: GlaxoSmithKline And Clover Team Up On Coronavirus Vaccine. Feb 24, 2020 236
Paradigm Biopharmaceuticals meets with US Food and Drug Administration to discuss development of flagship drug ZilosulA. Feb 22, 2020 300
Arecor pushes to meet unmet needs in diabetes care. Feb 22, 2020 434
ImmunoPrecise initiates coronavirus vaccine and therapeutic antibody programme. Feb 21, 2020 175
ImmunoPrecise initiates coronavirus vaccine and therapeutic antibody programme. Feb 21, 2020 179
Paradigm Biopharmaceuticals treats first US patient with ZilosulA. Feb 19, 2020 389
Navidea Biopharmaceuticals Gains USD 7.6m in Additional Funding. Feb 18, 2020 445
Navidea Biopharmaceuticals Regains Compliance with NYSE American Continued Listing Standards. Feb 18, 2020 326
Navidea Biopharmaceuticals reports USD7.6m in additional funding from Ohio Court judgment and equity. Feb 17, 2020 215
Navidea Biopharmaceuticals reports USD7.6m in additional funding from Ohio Court judgment and equity. Feb 17, 2020 211
Paradigm Biopharmaceuticals presents patient-centric research at World MPS Symposium. Feb 14, 2020 583
RegeneRx Biopharmaceuticals receives new patent from Canadian Patent Office to Henry Ford Health System. Feb 14, 2020 174
RegeneRx Biopharmaceuticals receives new patent from Canadian Patent Office to Henry Ford Health System. Feb 14, 2020 170
BetterLife Pharma Acquires Solmic to Boost Production Capabilities of CBD-Based Biopharmaceuticals. Feb 4, 2020 264
BetterLife Pharma Acquires Solmic to Boost Production Capabilities of CBD-Based Biopharmaceuticals. Feb 4, 2020 266
Therapeutic Proteins Market Global and Regional Analysis By Top Key Market Players 2022. Jan 28, 2020 574
Sebacia Acquires IP, Assets from Sienna Biopharmaceuticals. Jan 15, 2020 183
Sebacia Acquires IP, Assets from Sienna Biopharmaceuticals. Jan 15, 2020 194
Global Breast Cancer Drug Market Offers US$ 40 Billion Market Opportunity Across Multiple Drug Classes Like Vaccines, Antibodies, Small Molecule, Peptides & Radiopharmaceuticals. Jan 14, 2020 1069
The Week Ahead In Biotech: JPMorgan Healthcare Conference, FDA Panel Reviews Opioid Pain Drugs, I-Mab's IPO. Shanthi Rexaline Calendar Jan 12, 2020 518
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026. Jan 8, 2020 877
True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake. ANI Jan 6, 2020 368
Therapeutic Proteins Market Increasing Demand, Latest Trends & Huge Business Prospects In Healthcare Industry By 2020 / Radiant Insights, Inc. Dec 23, 2019 891
Antibody Drug Conjugate Market Therapeutic Analysis By Types, Technology and Global Industry Trends / MRFR Business Outlook 2019 To 2023. Industry overview Dec 18, 2019 804
Paradigm Biopharmaceuticals provides market update. Dec 13, 2019 350
RNA-based Biopharmaceuticals Market: Hints of Emerging Opportunities / Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories. Dec 10, 2019 1001
Sanofi and Regeneron announce intent to restructure Antibody collaboration for KevzaraA[R] (sarilumab) and PraluentA[R] (alirocumab). Dec 10, 2019 1622

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |